Source: Seeking Alpha
Gilead Sciences, Inc. (NASDAQ:GILD)
Q2 2014 Earnings Conference Call
July 23, 2014 05:00 PM ET
Executives
Patrick O’Brien – VP, IR
John Martin – Chairman and CEO
John Milligan – President and COO
Norbert Bischofberger – EVP, Research and Development and CSO
Paul Carter – EVP, Commercial Operations
Robin Washington – EVP and CFO
Analysts
Geoff Meacham – JPMorgan
Geoffrey Porges – Bernstein
Mark Schoenebaum – ISI Group
Brian Abrahams – Wells Fargo
Matthew Roden – UBS Securities
Michael Yee – RBC Capital Markets
Phil Nadeau – Cowen & Company
Yaron Werber – Citi
Ian Somaiya – Nomura Security
Ravi Mehrotra – Credit Suisse
Robyn Karnauskas – Deutsche Bank
Josh Schimmer – Piper Jaffray
Howard Liang – Leerink
Brian Skorney – Robert W Baird
Matthew Harrison – Morgan Stanley
Thomas Wei – Jefferies & Company
Terence Flynn – Goldman Sachs
Operator
Ladies and gentlemen, thank you for standing-by and welcome to the Gilead Sciences’ Second Quarter 2014 Earnings Conference Call. My name is Samiya, and I will be your conference operator today. At this time, all participants are in a listen-only-mode and as a reminder this conference call is being recorded.
I would now like to turn the call over to Patrick O’Brien, Vice President of Investor Relations. Please go ahead.
Patrick O’Brien – VP, IR
Thank you, Sam. Good afternoon, everyone. We issued a press release this afternoon providing earnings results for the second quarter, which is available on our Web site where you can also find detailed slides that support today’s call.
For our prepared remarks and Q&A, I am joined by our Chairman and Chief Executive Officer, John Martin; our President and Chief Operating Officer, John Milligan; our Executive Vice President of Research & Development, Norbert Bischofberger; our Executive Vice President of Commercial Operations, Paul Carter; and our Executive Vice President and Chief Financial Officer, Robin Washington.
Pages: First |1 | ... | Next → | Last | View Full Transcript